Microglial-oligodendrocyte interactions in myelination and neurological function recovery after traumatic brain

Shanshan Song1,2,3, Md Nabiul Hasan1,2,3, Lauren Yu1,2

  • 1Department of Neurology, University of Pittsburgh, 3501 Fifth Avenue, Pittsburgh, PA, 15213, USA.

Insights

Blocking the Na+/H+ exchanger (NHE1) in microglia promotes brain repair after traumatic brain injury (TBI). This reduces inflammation, aids oligodendrocyte regeneration, and accelerates functional recovery.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglial inflammatory responses influence oligodendrocyte (OL) differentiation and maturation in white matter.
  • The impact of traumatic brain injury (TBI) on microglia-OL crosstalk, axonal myelination, and neurological function is not well understood.
  • The Na+/H+ exchanger 1 (NHE1), a key microglial pH regulator, is implicated in TBI-induced inflammation and OL responses.

Purpose of the Study:

  • To investigate the role of microglial NHE1 in TBI-induced inflammation and its effects on oligodendrocyte survival and differentiation.
  • To evaluate the therapeutic potential of targeting NHE1 for TBI recovery.

Main Methods:

  • Utilized a murine model of TBI induced by controlled cortical impact.
  • Generated selective microglial Nhe1 knockout (Nhe1 cKO) mice (Cx3cr1-CreERT2;Nhe1flox/flox) and control littermates (Cx3cr1-CreERT2).
  • Administered a potent NHE1 inhibitor (HOE642) to wild-type TBI mice.
  • Assessed TBI-induced contusion volumes, white matter damage, oligodendrocyte regeneration, microglial phenotypes, and sensorimotor and cognitive functions.

Main Results:

  • Nhe1 cKO mice showed reduced initial white matter damage and enhanced chronic phase of OL regeneration post-TBI compared to controls.
  • Microglia and infiltrated myeloid cells in Nhe1 cKO brains exhibited anti-inflammatory phenotypes and reduced pro-inflammatory gene expression.
  • Nhe1 cKO mice demonstrated accelerated sensorimotor and cognitive functional recovery after TBI.
  • Pharmacological inhibition of NHE1 with HOE642 in wild-type TBI mice recapitulated the beneficial outcomes observed in Nhe1 cKO mice.

Conclusions:

  • Blocking NHE1 in microglia promotes a shift towards restorative microglial activation, enhancing oligodendrogenesis and neuroprotection.
  • Targeting NHE1 facilitates accelerated brain repair and neurological function recovery following TBI.
  • NHE1 inhibition represents a promising therapeutic strategy for mitigating TBI-induced damage and promoting recovery.